COVID-19: How safe are antiviral drugs for environment?

Both chloroquine and hydroxychloroquine, for example, pose serious chronic threat to the aquatic environment

AMR week: Antimalaria drug resistance not alarming but growing fast, says WHO report

Three states in India’s North East reported resistance to commonly used drug against malaria

Chloroquine does not inhibit SARS-CoV-2 spread in human lung cells: Study

The drug stops the spread of the virus that causes COVID-19 in African green monkey kidney cells, but is ineffective in human lung cells

Why do we need to worry about antimicrobial resistance in the time of COVID-19?

As more and more antimicrobials are used to control the virus and the co-infections, this indiscriminate use will further increase AMR

Donald Trump is taking hydroxychloroquine to ward off COVID-19. Is that wise?

There is a 20% genetic difference between SARS-CoV-2 and previous SARS coronavirus, meaning we should not assume a drug shown to act against SARS …

Fatal bacterial infections may stem from COVID-19 therapies, AMR a concern: Study

Researchers have found that SARS-CoV-2 and bacteria in lungs may affect each other’s ability to cause damage and worsen the outcome in a …

Ranbaxy launches new anti-malarial drug

It has an efficacy rate of over 95 per cent, claims company

COVID-19: HCQ fails in first randomised controlled trials in France, China

Both studies show significant adverse effects of the drug on moderate and serious patients